In the last trading session, 4.38 million Aptevo Therapeutics Inc (NASDAQ:APVO) shares changed hands as the company’s beta touched 5.59. With the company’s per share price at $1.49 changed hands at -$0.5 or -25.13% during last session, the market valuation stood at $2.17M. APVO’s last price was a discount, traded about -11993.29% off its 52-week high of $180.19. The share price had its 52-week low at $0.94, which suggests the last value was 36.91% up since then. When we look at Aptevo Therapeutics Inc’s average trading volume, we note the 10-day average is 11.0 million shares, with the 3-month average coming to 1.77 million.

Aptevo Therapeutics Inc (NASDAQ:APVO) trade information

Instantly APVO was in red as seen at the end of in last trading. With action 33.04%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -65.43%, with the 5-day performance at 33.04% in the green. However, in the 30-day time frame, Aptevo Therapeutics Inc (NASDAQ:APVO) is -44.40% down. Looking at the short shares, we see there were 0.12 million shares sold at short interest cover period of 2.61 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 80.96%. The 2025 estimates are for Aptevo Therapeutics Inc earnings to increase by 81.87%, but the outlook for the next 5-year period is at 51.40% per year.

APVO Dividends

Aptevo Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Feb-13.

Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.01% of Aptevo Therapeutics Inc shares while 4.85% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.85%.